Drug companies see a chance to cripple 340B, a program they once championed. The about-face by the pharmaceutical industry is surprising, given that drug makers lobbied aggressively for the 2010 Affordable Care Act (ACA) knowing it would expa...Source: https://www.americanthinker.com/article ... plier.html